Latest Coronavirus Disease COVID 19 News and Research
_on_human_skin-Tacio_Philip-1000_63ca0542f3674714a09eca4dc8beabab-150x125.jpg "T cells can counteract dangerous phenomenon of mosquito-borne viruses")
T cells can counteract dangerous phenomenon of mosquito-borne viruses
Every year, more than 68,000 people end up with a clinical case of Japanese encephalitis. One in four of these patients will die. The mosquito-borne virus, which is most common in Southeast Asia, also causes severe neurological damage and psychiatric disorders.
Social media fears about lack of coverage for protest injuries may be overblown
Thousands of protesters thronged the streets in recent days to express their anger over the killing of an African American man, George Floyd, in police custody in Minneapolis.
A roadmap to help older Britons struggling with 'shopping lists' of medication
New research provides a roadmap to help the millions of older Britons struggling with 'shopping lists' of medication, as fears grow that the current coronavirus lockdown could be further isolating the most vulnerable.
_532be0cf94584fcf92bb93f947043861-150x125.jpg "Antiviral effects for COVID-19: Early is better")
Antiviral effects for COVID-19: Early is better
A new study by an international team of researchers and published on the preprint server medRxiv* in June 2020 describes the possible reasons for inconsistent or null findings in clinical studies of antiviral drugs to date. It proposes a new approach to decide the sample size in light of its findings.
Precautions for intimacy, sex, during COVID-19
Amid the coronavirus disease (COVID-19) pandemic, safe sex practices are as important as other measures to prevent infection. Little focus has been given to sexual health, but a new study highlights how couples can reduce the transmission of the novel coronavirus.
WHO resumes hydroxychloroquine drug trial in COVID-19
The coronavirus disease (COVID-19) has rippled across the world with a devastating effect. As scientists raced to find an effective treatment for patients, existing malaria and rheumatoid arthritis drug hydroxychloroquine became one of the most popular candidates.
Study: Eggs can be used as low-cost coating to protect fruits and vegetables
Eggs that would otherwise be wasted can be used as the base of an inexpensive coating to protect fruits and vegetables, according to Rice University researchers.
U.K. doctors test lipid ibuprofen as COVID-19 treatment
The non-steroidal anti-inflammatory drug (NSAID) Ibuprofen is being tested as a potential treatment for the coronavirus disease (COVID-19). Doctors in the United Kingdom rolled out a clinical trial of the everyday painkiller to see if it reduces respiratory failure in patients experiencing severe COVID-19 disease.
A SARS-CoV-2 antibody magnetic immuno-detection test
A new report, released on the preprint server bioRxiv by researchers at the Fraunhofer Institute for Molecular Biology and Applied Ecology, describes the development of an innovative serologic test that could provide a fast, easy, and inexpensive method of detecting high titers of antibody in the serum of SARS-CoV-2 infected people.
Designing a prototype spike protein vaccine for SARS-CoV-2
A recent study published on the preprint server bioRxiv in June 2020 reports the development of a prototype vaccine containing multiple antigenic sites, based on the spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is causing the current COVID-19 pandemic. If successful, this could lead to the development of an effective, non-allergenic vaccine that induces both humoral and cellular immunity.
_38a8cea3044e423dab2dbadd967c33ec-150x125.jpg "Comparing genomes to understand how mutations affect the COVID-19 pandemic")
Comparing genomes to understand how mutations affect the COVID-19 pandemic
Now, a new study by researchers at the Massachusetts Institute of Technology and the Center for Computational Biology, Flatiron Institute and published online on the bioRxiv preprint server describes how the use of comparative genomics helps to identify protein-coding and non-coding functional genes.
_1dd9793147bf46e897466fd1c8609f3f-150x125.jpg "SARS-CoV-2 gene deletions may cause milder infections and increase human-to-human transmission")
SARS-CoV-2 gene deletions may cause milder infections and increase human-to-human transmission
In their recent paper released on the bioRxiv preprint server, a research group from Spain demonstrated how genome changes and deletions in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could represent a strategy of natural selection used for lessening the impact of infection in order to increase viral transmission potential.
Alpaca-derived antiviral agent neutralizes SARS-CoV-2
Researchers at Karolinska University Hospital and the University of Cape Town have identified an antibody fragment that targets the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein and potently neutralizes the virus.
Scientists aim to develop a gene-targeting, antiviral agent against COVID-19
A team of scientists from Stanford University is working with researchers at the Molecular Foundry, a nanoscience user facility located at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab), to develop a gene-targeting, antiviral agent against COVID-19.
Potential new immunotherapy for critical COVID-19
Researchers at the Chongqing Medical University in China have identified a cytokine that could serve as a potential candidate for treating patients with severe coronavirus disease 2019 (COVID-19).
New initiative to determine extent of COVID-19 infections in Virginia
UVA Health has partnered with the Virginia Department of Health and other hospitals around the state to determine how many Virginians have been infected with COVID-19 - and how many remain at risk.
DFG to establish ten new Collaborative Research Centers
The Deutsche Forschungsgemeinschaft is establishing ten new Collaborative Research Centres to further support top-level research in German universities.
Efforts to curb congenital syphilis falter in COVID’s shadow
U.S. public health officials are closer to identifying a road map for curbing the rising rates of syphilis infections in newborn babies, but with so many resources diverted to stopping the spread of COVID-19, many fear the rate of deadly infections will only get worse.
_16e7ee38d08243b28abb6700a49f2962-150x125.jpg "KHN’s ‘What the Health?’: Protests and the pandemic")
KHN’s ‘What the Health?’: Protests and the pandemic
Following the death of George Floyd while in custody in Minneapolis, protests have mushroomed around the U.S. to decry police violence, raising concerns among public health officials about the potential for further spread of the coronavirus.
Hydroxychloroquine not able to prevent development of COVID-19, UMN trial shows
Today, University of Minnesota Medical School researchers published the results from the first randomized clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19.
No hay comentarios:
Publicar un comentario